Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma

World Journal of Gastroenterology

Volumn 8, Issue 4, 2002, Pages 668-673

  Zhou, Chong Zhi ^a   Peng, Zhi Hai ^a   Zhang, Fang ^a   Qiu, Guo Qiang ^a   He, Lin ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CHI SQUARE TEST; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME ARM; CLINICAL FEATURE; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; COMPUTER PROGRAM; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ELECTROPHORESIS; FEMALE; FREQUENCY ANALYSIS; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PATHOGENESIS; POLYMERASE CHAIN REACTION; RECTUM CANCER; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

EID: 0036678430     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i4.668     Document Type: Article

References (61)

1. A genetic model for colorectal tumorigenesis
2. ABC of colorectal cancer: Molecular basis for risk factors
3. Aberration of p53 and DCC in gastric and colorectal cancer
4. Genetic instabilities in human cancers
5. Allelotype of colorectal carcinomas
6. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer
7. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
8. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers
9. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
10. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC
11. Loss of heterozygosity on chromosome 3 in sporadic colorectal carcinoma
12. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer
13. Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers
14. Mapping of genetic deletions on the long arm of chromosome 22 in human pancreatic adenocarcinomas
15. Constitutional translocation t(4;22)(q12;q12.2) associated with neurofibromatosis type 2
16. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor
17. Structural analysis of the human pro-apoptotic gene Bik: Chromosomal localization, genomic organization and localization of promoter sequences
18. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis
19. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations
20. Characterisation of 16 polymorphic markers in the NF2 gene: Application to hemizygosity detection
21. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH
22. Mosaicism in sporadic neurofibromatosis 2 patients
23. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors
24. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor
25. Functional analysis of neurofibromatosis 2 (NF2) missense mutations
26. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation
27. Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis
28. Allelic loss on chromosome 22q in epithelioid sarcomas
29. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
30. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations
31. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers
32. Neurofibromatosis 2 gene in human colorectal cancer
33. Systemic tumor suppression by the proapoptotic gene bik
34. Analysis of E1A-mediated growth regulation functions: Binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity
35. Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis
36. p300 gene alterations in colorectal and gastric carcinomas
37. Mutations truncating the EP300 acetylase in human cancers
38. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins
39. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K
40. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines
41. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells
42. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential
43. Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location
44. Are right- and left-sided colon neoplasms distinct tumors?
45. Different mechanisms in the tumorigenesis of proximal and distal colon cancers
46. Mechanisms of oncogenesis in colon versus rectal cancer
47. p53 alterations are associated with improved prognosis in distal colonic carcinomas
48. p53 expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern and short-term survival
49. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q
50. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12
51. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer
52. Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA
53. Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas
54. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer
55. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers
56. Allelic loss on chromosome 22 in oral cancer: Possibility of the existence of a tumor suppressor gene on 22q13
57. Genetic alterations in gastric cancers from British patients
58. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma
59. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line
60. Chromosome 22q a frequent site of allele loss in head and neck carcinoma
61. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications